RISK FACTORS FOR GLAUCOMA DRAINAGE DEVICE FAILURE IN GLAUCOMA PATIENTS
Published 2025 - 29th ESCRS Winter Meeting
Reference: FP03.07 | Type: Free Paper | DOI: 10.82333/ftwd-rr48
Authors: Nader Nassiri* 1 , Maryam Yadgari 1 , Kourosh Sheibani 2 , Sara Kavousnezhad 3
1Ophthalmology,Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences ,Tehran,Iran, Islamic Republic Of, 2Basir Eye Health Research Center,Tehran,Iran, Islamic Republic Of, 3Vanak Eye Surgery Center,Tehran,Iran, Islamic Republic Of
Purpose
To investigate the Risk factors for AGV ( Ahmed glaucoma valve) failure.
Setting
Imam Hossein nMedical Center, Tehran, Iran.
Methods
A retrospective analysis of patients' medical records with varying glaucoma causes who underwent AGV implantation. The primary measure of success was the cumulative achievement of an intraocular pressure (IOP) between 5 and 21 mmHg, with a 20 % reduction from baseline, with or without medication to lower IOP. The secondary measures of success were IOP levels and the number of glaucoma medications used.
Results
The study enrolled 120 participants, with an average age of 48.9 ± 19.6 years of age. The average follow-up period was 4.5 ± 1.4 years. The mean survival duration was 5.3 ± 0.5 years in patients with hypertensive phase (HP), which was significantly shorter than the 6.4 ± 0.2 years in those without HP. The likelihood of surgical failure was also correlated with higher baseline IOP, with an odds ratio of 1.07 (95 % confidence interval: 1.02-1.12). In a logistic regression model, the presence of neovascular glaucoma was the only factor significantly associated with AGV failure, with an odds ratio of 3.14 (95 % confidence interval: 1.2-8.1).
Conclusion
Based on our findings neovascular glaucoma, a higher baseline IOP and the presence of hypertensive phase are risk factors for AGV failure.